Significance of examination of prostate-specific antigen and prostate-specific antigen density in patients with prostatic hyperplasia and prostate cancer
β Scribed by I. Romics; D. Frang; I. Bodrogi
- Book ID
- 110553446
- Publisher
- Springer Netherlands
- Year
- 1997
- Tongue
- English
- Weight
- 501 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0301-1623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Prostate-specific antigen (PSA) is the most accurate serum marker for cancer of the prostate (CAP). However, its sensitivity and specificity are suboptimal, especially at values ranging between 4.1 and 10.0ng/ml (monoclonal), because benign prostatic hypertrophy and hyperplasia (BPH) and CaP frequen
## Abstract Prostateβspecific antigen (PSA), as measured in peripheral blood, is currently the most widely used marker for the assessment of tumor burden in the longitudinal study of patients with carcinoma of the prostate (PCA). Studies from other laboratories have led to the conclusion that a giv